2921.11.00 | 00 | Acyclic monoamines and their derivatives; salts thereof: | | | | |
2921.19.11 | 00 | Mono-, di- and triethylamines; mono-, di-, and tri-(propyl- and butyl-)monoamines; salts of any of the foregoing | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
2921.21.00 | 00 | Acyclic polyamines and their derivatives; salts thereof: | | | | |
2921.30 | | Cyclanic, cyclenic or cycloterpenic mono- or polyamines, and their derivatives; salts thereof: | | | | |
2921.41 | | Aromatic monoamines and their derivatives; salts thereof: | | | | |
2921.43 | | Toluidines and their derivatives; salts thereof: | | | | |
2921.44 | | Diphenylamine and its derivatives; salts thereof: | | | | |
2921.45 | | 1-Naphthylamine ( α-Naphthylamine), 2-Naphthylamine ( β-Naphthylamine), and their derivatives; salts thereof: | | | | |
2921.45.20 | 00 | 3-Amino-2,7-naphthalenedisulfonic acid; 4-Amino-1-naphthalenesulfonic acid, sodium salt; 5-Amino-1-naphthalenesulfonic acid (Laurent's acid); 8-Amino-2-naphthalenesulfonic acid and its salts; 7-Amino-1,3,6-naphthalenetrisulfonic acid; 8-Anilino-1-naphthalenesulfonic acid (Phenyl Peri acid) and its salts; and N-Ethyl-1-naphthylamine | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,L,MA,MX, P,SG) | 15.4¢/kg + 39.5% |
2921.45.25 | 00 | Mixtures of 5- and 8-amino-2-naphthalene- sulfonic acid; 2-Naphthylamine-6-sulfonic acid; and o-Naphthionic acid (1-amino- 2-naphthalene- sulfonic acid) | kg | Free | | 15.4¢/kg + 60% |
2921.46.00 | 00 | Amfetamine (INN), benzfetamine (INN), dexamfetamine (INN), etilamfetamine (INN), fencamfamin (INN), lefetamine (INN), levamfetamine (INN), mefenorex (INN) and phentermine (INN); salts thereof | kg | Free | | 15.4¢/kg + 149.5% |
2921.49.38 | 00 | Antidepressants, tranquilizers and other psychotherapeutic agents | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4¢/kg + 149.5% |
2921.51 | | Aromatic polyamines and their derivatives; salts thereof: | | | | |
2921.51 | | o-, ¢/ p-Phenylenediamine, diaminotoluenes, and their derivatives; salts thereof: | | | | |
2922.11.00 | 00 | Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters; salts thereof: | | | | |
2922.21 | | Amino-naphthols and other amino-phenols, other than those containing more than one kind of oxygen function, their ethers and esters; salts thereof: | | | | |
2922.29.10 | 00 | 2-Amino-6-chloro-4-nitrophenol; 2-Amino-4-chlorophenol; 2-Amino-4-chlorophenol hydrochloride; 2-Amino-p-cresol; 4-Amino-o-cresol; 6-Amino-2,4-dichloro-3-methylphenol; 2-(3-Amino-4-hydroxyphenylsulfonyl)ethanol; 2-Amino-4-nitrophenol; 2-Amino-4-nitrophenol, sodium salt; 2-Amino-5-nitrophenol; m-Aminophenol; 2-(4'-Aminophenoxy)ethylsulfate; 5-Chloro-2-(2',4'-dichlorophenoxy)aniline; 3,4-Dimethoxyphenethylamine (Homoveratrylamine); 2-Hydroxy-5-nitrometanilic acid; 4-Methoxymetanilic acid; 6-Methoxymetanilic acid; 4-Methoxy-m-phenylenediamine; 5-Methoxy-m-phenylenediamine sulfate; 6-(Methylamino)-1-naphthol-3-sulfonic acid; 7-(Methylamino)-1-naphthol-3-sulfonic acid; and 2-Methyl-p-anisidine | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P,SG) | 15.4¢/kg + 39% |
2922.29.15 | 00 | m-Diethylaminophenol; m-Dimethylaminophenol; 3-Ethylamino-p-cresol; and 5-Methoxy-m-phenylenediamine | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,L,MA,MX, P,SG) | 15.4¢/kg + 51% |
2922.31.00 | 00 | Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof: | | | | |
2922.31.00 | 00 | Amfepramone (INN), methadone (INN) and normethadone (INN); salts thereof | kg | Free | | 15.4¢/kg + 50% |
2922.41.00 | | Amino-acids, other than those containing more than one kind of oxygen function, and their esters; salts thereof: | | | | |
2922.41.00 | | Lysine and its esters; salts thereof | | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
2922.41.00 | 10 | Meeting requirements of Food Chemical Codex, Codex Alimentarius or United States Pharmacopeia | kg | | | |
2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5¢/kg + 30% |
2924.11.00 | 00 | Acyclic amides (including acyclic carbamates) and their derivatives; salts thereof: | | | | |